Csenge Advisory Group’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,738	Closed	-$554K	–	778
2025 Q2	$554K	Buy	1,738 +192	+12%	+$57.4K	0.03%	404
2025 Q1	$440K	Sell	1,546 -245	-14%	-$84K	0.03%	426
2024 Q4	$632K	Sell	1,791 -271	-13%	-$99.6K	0.03%	371
2024 Q3	$739K	Buy	2,062 +295	+17%	+$99.7K	0.04%	341
2024 Q2	$563K	Buy	1,767 +310	+21%	+$82K	0.03%	375
2024 Q1	$335K	Buy	1,457 +23	+2%	+$5.19K	0.02%	520
2023 Q4	$315K	Sell	1,434 -80	-5%	-$18.4K	0.02%	511
2023 Q3	$342K	Buy	1,514 +195	+15%	+$44.9K	0.02%	460
2023 Q2	$291K	Buy	1,319 +78	+6%	+$17.3K	0.02%	508
2023 Q1	$278K	Sell	1,241 -87	-7%	-$21.4K	0.02%	486
2022 Q4	$369K	Buy	+1,328	New	+$335K	0.03%	417
2018 Q4	–	Sell	-11	Closed	-$1K	–	1426
2018 Q3	$1K	Buy	+11	New	+$1.36K	﹤0.01%	937